ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,644, issued on March 24, was assigned to President and Fellows of Harvard College (Cambridge, Mass.) and The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"O-GlcNAc transferase inhibitors and uses thereof" was invented by Suzanne Walker Kahne (Cambridge, Mass.), Sara Evelyn Schwanger Martin (Cambridge, Mass.), Craig Joseph Thomas (Gaithersburg, Md.) and Damien Yves Duveau (Germantown, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are O-GlcNAc transferase (OGT) inhibitor compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polym...